GOVX:NASDAQ
Geovax Labs Inc
$0.36
arrow_downward
-6.81%(-0.026) 1D
Sep 18, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GOVX...
Open
$0.39
High
$0.39
Low
$0.36
Mkt. cap
3.27M
Avg. vol.
948.32K
Volume
163.00
52-wk high
$17.50
52-wk low
$0.36
EPS
-$13.92
Beta
3.66
Shares outstanding
10.10M
No. of employees
19
Open
$0.39
High
$0.39
Low
$0.36
Mkt. cap
3.27M
Avg. vol.
948.32K
Volume
163.00
52-wk high
$17.50
52-wk low
$0.36
EPS
-$13.92
Beta
3.66
Shares outstanding
10.10M
No. of employees
19
News stories
From web sources and news partners
careplusvn.com
·
1 month ago
GOVX Q2 2026 Earnings: EPS Surprises Positively Despite Revenue Absence - Earnings Season Review
Profile
GeoVax is a clinical-stage biotechnology company which develops vaccines. GeoVax's development platform uses Modified Vaccinia Ankara vector technology, with improvements to antigen design and manufacturing capabilities. GeoVax uses recombinant DNA or recombinant viruses to produce virus-like particles in the person being vaccinated. Wikipedia
About Geovax Labs Inc
CEODavid A. Dodd
Employees19
Founded1988
HeadquartersAtlanta, Georgia, United States
SectorBiotechnology
Websitegeovax.com